The deal with Metaphore Biotechnologies is the third to emerge from a Flagship alliance that’s meant to boost the Danish drugmaker’s pipeline of weight loss medicines.

The move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but struggled to sell it amid competition and the emergence of rare but serious side effects.

Research breakthroughs on Inflammatory Bowel Disease (IBD) are fervently sought, aiming to raise global healthcare ...

Takeda has good company in restructuring its business, joining other large pharmas like Bristol Myers Squibb, Bayer, Sanofi and Novartis that have recently cut back on spending, laid off staff or ...

The deal gives the company milestone payments and royalties to a medicine that Sanofi licensed from biotech ImmuNext and expects to be a future blockbuster. With frexalimab in its portfolio, Royalty ...

Intellectual property is the foundation of the drug industry’s business model. This database will track key patent expiry dates for 30 top-selling medicines.

Crafting a professional career doesn’t always go according to design. Despite carefully laid plans, twists and turns arise and unexpected opportunities unfold. That’s certainly the case with Leen ...

Pfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The company is working with trial researchers to investigate further.

We are absolutely thrilled to welcome Jonathan into this critical leadership role for Sapient,” said Mo Jain, MD, PhD, Founder and CEO of Sapient. “He is a rare talent possessing both deep scientific ...

The $200 million round is the latest evidence that surging interest in autoimmune disease cell therapies could expand to include developers of bispecific antibodies, too.

Weeks after a safety setback derailed its lead candidate, the company has treated the first participant in a trial of its heart disease treatment Verve-102.

The honor is underscored by recent news highlighting the strength of the PumasAI team and its technology for the pharmaceutical industry, including: A focus on leading industry workshops to further ...